Yan Feng

5PUBLICATIONS
74CO-AUTHORS
AllergyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2026
A phase I, randomized, dose-escalation clinical trial of the anti-IgE humanized monoclonal antibody LP-003 in healthy subjects.

|Mar 24, 2026
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis.

Yuan Zhang, Jingyun Li, Xian Li

|Jun 23, 2025
LP-003, a novel high-affinity anti-IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial.

Kai Guan, Shuang Liu, Yan Feng

|Oct 16, 2024
Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter Study.

Rundong Qin, Yan Feng, Huanping Zhang

|Feb 23, 2024
Three Artemisia pollens trigger the onset of allergic rhinitis via TLR4/MyD88 signaling pathway.

Jing Zhang, Lu Gao, Dongdong Yu

Pageof 1

Frequent Collaborators

2 joint publications

Qingyu Wei

1 joint publications

Jinhong Li

1 joint publications

Xiaoming Zhu

1 joint publications

Heng Liu